Aimmune Therapeutics, Inc. (NASDAQ: AIMT)

Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its board of directors concerning the proposed acquisition of the company by Nestlé S.A. Stockholders will receive $34.50 in cash for each share of Aimmune Therapeutics stock that they hold. The transaction is valued at approximately $2.6 billion and […]

Aimmune Therapeutics, Inc. (NASDAQ: AIMT)2020-11-02T16:51:28+00:00

BMC Stock Holdings, Inc. (NASDAQ: BMCH)

Rowley Law PLLC is investigating potential securities law violations by BMC Stock Holdings, Inc. (NASDAQ: BMCH) and its board of directors concerning the proposed acquisition of the company by Builders FirstSource, Inc. (NASDAQ: BLDR). Stockholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC Stock Holdings stock that they hold. […]

BMC Stock Holdings, Inc. (NASDAQ: BMCH)2020-11-02T16:51:21+00:00

Proteostasis Therapeutics, Inc. (NASDAQ: PTI)

Rowley Law PLLC is investigating potential securities law violations by Proteostasis Therapeutics, Inc. (NASDAQ: PTI) and its board of directors concerning the proposed acquisition of the company by Yumanity Therapeutics. Proteostasis Therapeutics stockholders will own approximately 32.5% of the combined company. The transaction is expected to close in the fourth quarter of 2020.

If you […]

Proteostasis Therapeutics, Inc. (NASDAQ: PTI)2020-10-26T15:52:26+00:00

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

Rowley Law PLLC is investigating potential securities law violations by Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) and its board of directors concerning the proposed acquisition of the company by members of the Company’s senior management and other investors. Stockholders will receive $19.75 in cash for each share of Cellular Biomedicine Group stock that they hold. […]

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)2020-10-16T18:00:23+00:00

Montage Resources Corporation (NYSE: MR)

Rowley Law PLLC is investigating potential securities law violations by Montage Resources Corporation (NYSE: MR) and its board of directors concerning the proposed acquisition of the company by Southwestern Energy Company (NYSE: SWN). Stockholders will receive 1.8656 shares of Southwestern Energy common stock for each share of Montage Resources stock that they hold. The transaction […]

Montage Resources Corporation (NYSE: MR)2020-10-16T18:00:18+00:00

GCI Liberty, Inc. (NASDAQ: GLIBA)

Rowley Law PLLC is investigating potential securities law violations by GCI Liberty, Inc. (NASDAQ: GLIBA) and its board of directors concerning the proposed acquisition of the company by Liberty Broadband Corporation (NASDAQ: LBRDA, LBRDK). Class A stockholders will receive 0.580 shares of Liberty Broadband’s LBRDK common stock for each share of GCI Liberty’s GLIBA stock […]

GCI Liberty, Inc. (NASDAQ: GLIBA)2020-08-07T16:56:27+00:00

Livongo Health, Inc. (NASDAQ: LVGO)

Rowley Law PLLC is investigating potential securities law violations by Livongo Health, Inc. (NASDAQ: LVGO) and its board of directors concerning the proposed acquisition of the company by Teladoc Health (NYSE: TDOC). Stockholders will receive $11.33 in cash and 0.5920 shares of Teladoc Health common stock for each share of Livongo stock that they hold. […]

Livongo Health, Inc. (NASDAQ: LVGO)2020-10-16T18:00:11+00:00

Jernigan Capital, Inc. (NYSE: JCAP)

Rowley Law PLLC is investigating potential securities law violations by Jernigan Capital, Inc. (NYSE: JCAP) and its board of directors concerning the proposed acquisition of the company by NexPoint Advisors, L.P. Stockholders will receive $17.30 in cash for each share of Jernigan Capital stock that they hold. The transaction is valued at approximately $900 million […]

Jernigan Capital, Inc. (NYSE: JCAP)2020-10-02T16:41:37+00:00

Varian Medical Systems, Inc. (NYSE: VAR)

Rowley Law PLLC is investigating potential securities law violations by Varian Medical Systems, Inc. (NYSE: VAR) and its board of directors concerning the proposed acquisition of the company by Siemens Healthineers AG. Stockholders will receive $177.50 in cash for each share of Varian stock that they hold. The transaction is valued at approximately $16.4 billion […]

Varian Medical Systems, Inc. (NYSE: VAR)2020-10-02T16:41:48+00:00

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

Rowley Law PLLC is investigating potential claims for breach of fiduciary duty involving the directors and officers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).

If you are a stockholder of Regeneron Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact […]

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)2020-10-02T16:41:25+00:00
Go to Top